Yahav Achim Ve Achayot - Provident Funds Management Company’s AstraZeneca AZN Stock Holding History

Yahav Achim Ve Achayot - Provident Funds Management Company’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,900	Closed	-$937K	–	42
2023 Q3	$937K	Hold	6,900	–	–	0.81%	32
2023 Q2	$981K	Hold	6,900	–	–	0.75%	36
2023 Q1	$955K	Sell	6,900 -4,400	-39%	-$592K	0.94%	41
2022 Q4	$1.54M	Hold	11,300	–	–	1.46%	21
2022 Q3	$1.24M	Hold	11,300	–	–	1.2%	29
2022 Q2	$1.48M	Hold	11,300	–	–	1.33%	25
2022 Q1	$1.49M	Hold	11,300	–	–	1.15%	32
2021 Q4	$1.32M	Hold	11,300	–	–	0.95%	35
2021 Q3	$1.36M	Buy	+11,300	New	+$1.32M	1.07%	34

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Yahav Achim Ve Achayot - Provident Funds Management Company's AZN Position: Q4 2023 in Review

Yahav Achim Ve Achayot - Provident Funds Management Company sold out of AstraZeneca (AZN) in Q4 2023, closing a stake of 6,900 shares — an estimated $937K sold.

Yahav Achim Ve Achayot - Provident Funds Management Company first reported a position in AZN in Q3 2021 and held it in 9 quarters. The position peaked at $1.54M in Q4 2022. 1,131 funds tracked by Wall St. Rank hold AZN as of Q4 2023.

Yahav Achim Ve Achayot - Provident Funds Management Company reported no remaining AstraZeneca position as of Q4 2023 after selling out during the quarter.
Yahav Achim Ve Achayot - Provident Funds Management Company sold 6,900 AstraZeneca shares in Q4 2023, an estimated $937K.
Yahav Achim Ve Achayot - Provident Funds Management Company first reported a position in AstraZeneca in Q3 2021 and held it in 9 quarters.
Yahav Achim Ve Achayot - Provident Funds Management Company's AstraZeneca position peaked at $1.54M in Q4 2022.
1,131 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2023.

Based on Yahav Achim Ve Achayot - Provident Funds Management Company's 13F filing for Q4 2023, filed 15 Feb 2024.